טוען...
Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts
OBJECTIVES: To develop and validate a genetic tool to predict age of onset of aggressive prostate cancer (PCa) and to guide decisions of who to screen and at what age. DESIGN: Analysis of genotype, PCa status, and age to select single nucleotide polymorphisms (SNPs) associated with diagnosis. These...
שמור ב:
הוצא לאור ב: | BMJ |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
BMJ Publishing Group Ltd.
2018
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5759091/ https://ncbi.nlm.nih.gov/pubmed/29321194 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.j5757 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|